Select             pdf
Trial Studied trt Control trt patientstagsROB Trial resultCardiovascular deathmacrovascular events

diabetes type 2  

ROADMAP, 2010        NCTolmesartanplaceboLow risk of bias suggesting 396%-12%
ORIENT    NCTolmesartanplaceboLow risk of bias negative236%

diabetic kidney disease  

ORIENT    NCTolmesartanplaceboLow risk of bias negative236%

miscellaneous  

ROADMAP, 2010        NCTolmesartanplaceboLow risk of bias suggesting 396%-12%
ORIENT    NCTolmesartanplaceboLow risk of bias negative236%